EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

High‐grade vulvar intraepithelial neoplasia: comprehensive characterization and long‐term vulvar carcinoma risk

Nikki B Thuijs iD, Marc van Beurden, Sylvia Duin, Daniëlle A M Heideman, Johannes Berkhof, Renske D M Steenbergen, Maaike C G Bleeker iD

Histopathology · 2024

DOI: 10.1111/his.15050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, 2024. Verfasst von Nikki B Thuijs und 6 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam UMC Location Vrije Universiteit Amsterdam, Pathology, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Papillomavirus Infections, Vulvar Neoplasms, Carcinoma in Situ, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Dutch Cancer Society, KWF Kankerbestrijding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Adequate diagnosis of human papillomavirus (HPV)‐associated high‐grade squamous intraepithelial lesion (HSIL) and HPV‐independent vulvar intraepithelial neoplasia (VIN) is essential but can be challenging. We comprehensively characterized a large population‐based series of vulvar lesions, originally reported as high‐grade VIN, and assessed the cancer risk. Methods and results Baseline high‐grade VIN of 751 patients were categorized by histopathological reassessment, integrating the results of immunohistochemistry (p16 INK4a , p53, Ki‐67) and HPV DNA testing. Integrated analyses resulted in 88.4% HPV‐associated lesions (77.0% HSIL, 10.9% low‐grade SIL [LSIL], and 0.4% vulvar squamous cell carcinoma [VSCC]), 10.9% HPV‐independent lesions (6.1% HPV‐independent VIN, 4.7% nondysplastic lesions, and 0.1% VSCC) and 1.1% inconclusive lesions. HSIL demonstrated p16 INK4a block‐positivity in 99.0%, increased Ki‐67 in ≥2/3rd of the epithelium in 93.6%, and HPV positivity in 99.6%. In HSIL, a p53 wildtype mid‐epithelial staining pattern was common (51.6%) while this was not observed in HPV‐independent lesions. HPV‐independent VIN harboured mutant p53 patterns in 65.2% and showed a wide morphological spectrum, ranging from differentiated to nondifferentiated (‘HPV‐associated‐like’, in 41.3%). Kaplan–Meier analyses showed a 10‐year cancer risk of 8.0% in HPV‐associated HSIL, 67.4% in HPV‐independent VIN/p53mutant, and 27.8% in HPV‐independent VIN/p53wildtype. Strikingly, the 10‐year cancer risk was 73.3% in HPV‐independent VIN with nondifferentiated (‘HPV‐associated‐like’) morphology.

Conclusion

Immunohistochemistry by p16 INK4a and p53 is highly recommended for optimal categorization into HPV‐associated and HPV‐independent VIN, which is of utmost importance given the different cancer risk. The high cancer risk of HPV‐independent VIN underscores the need for surgical treatment and close follow‐up, especially in case of a p53 mutant pattern and/or nondifferentiated morphology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsVulvar NeoplasmsCarcinoma in SituCarcinoma, Squamous CellFemaleHumansCyclin-Dependent Kinase Inhibitor p16Ki-67 AntigenTumor Suppressor Protein p53Papillomaviridae

Stichwörter der Autor:innen

HPVHSILcancer riskdVINvulvar intraepithelial neoplasia

Substanzen

Cyclin-Dependent Kinase Inhibitor p16Ki-67 AntigenTumor Suppressor Protein p53

Autor:innen und Institutionen

  • Amsterdam UMC Location Vrije Universiteit Amsterdam, Pathology, Amsterdam, the Netherlands.
  • Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.
  • Netherlands Cancer Institute/Antoni Van Leeuwenhoek Hospital, CGOA, Gynecology, Amsterdam, the Netherlands.
  • Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Amsterdam UMC Location Vrije Universiteit Amsterdam, Epidemiology and Data Science, Amsterdam, the Netherlands.

ORCID-Profile: Nikki B Thuijs, Maaike C G Bleeker

Förderung

  • Dutch Cancer Society
  • KWF Kankerbestrijding

Zitieren

APA

Thuijs, N. B., van Beurden, M., Duin, S., Heideman, D. A. M., Berkhof, J., Steenbergen, R. D. M., & Bleeker, M. C. G. (2024). High‐grade vulvar intraepithelial neoplasia: comprehensive characterization and long‐term vulvar carcinoma risk. Histopathology. https://doi.org/10.1111/his.15050

Vancouver

Thuijs NB, van Beurden M, Duin S, Heideman DAM, Berkhof J, Steenbergen RDM, et al. High‐grade vulvar intraepithelial neoplasia: comprehensive characterization and long‐term vulvar carcinoma risk. Histopathology. 2024. doi:10.1111/his.15050

BibTeX
@article{Thuijs2024,
  author = {Thuijs, Nikki B and van Beurden, Marc and Duin, Sylvia and Heideman, Daniëlle A M and Berkhof, Johannes and Steenbergen, Renske D M and Bleeker, Maaike C G},
  title = {High‐grade vulvar intraepithelial neoplasia: comprehensive characterization and long‐term vulvar carcinoma risk},
  journal = {Histopathology},
  year = {2024},
  doi = {10.1111/his.15050}
}
Kostenlos starten →